| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics, Inc. | CEO and CFO, Director | Restricted Stock Units | 0 | $0.9100 | 28 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024043424-marchio-albert-n-ii-2024-04-05 | NexImmune, Inc. | 05 Apr 2024 | 0 | $0 | 3 | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | 10 Apr 2024, 17:13 |
| /report/000162828024000949-marchio-albert-n-ii-2023-12-28 | Fresh Tracks Therapeutics, Inc. | 28 Dec 2023 | 1 | -$1,138 | 4 | CEO and CFO, Director | 09 Jan 2024, 16:10 |
| /report/000081905023000006-marchio-albert-n-ii-2023-01-24 | Fresh Tracks Therapeutics, Inc. | 24 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 26 Jan 2023, 17:48 |
| /report/000081905022000046-marchio-albert-n-ii-2022-05-05 | Brickell Biotech, Inc. | 05 May 2022 | 1 | $0 | 4 | Chief Financial Officer | 09 May 2022, 16:16 |
| /report/000081905021000090-marchio-albert-n-ii-2021-06-14 | Brickell Biotech, Inc. | 14 Jun 2021 | 1 | $0 | 4 | Chief Financial Officer | 14 Jun 2021, 16:46 |